Tonix Pharmaceuticals Holding Corp (TNXP) Stock Analysis

Tonix Pharmaceuticals Holding Corp (TNXP) is a publicly traded company in the HEALTHCARE sector. It trades at $11.72, carries a market capitalization of $195.91M. This page summarizes the public market data, fundamentals, and frequently asked questions for TNXP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $11.72
• Market Cap: $195.91M
• EPS: $-14.66
• 52-Week High: $69.97
• 52-Week Low: $11.60

Market Sentiment

Tonix Pharmaceuticals Holding Corp currently has a Bullish sentiment score of 0.31.

About Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp. (TNXP) is a biopharmaceutical company based in Chatham, New Jersey, specializing in the development of innovative therapies for central nervous system disorders and rare diseases. The company is committed to addressing unmet medical needs, particularly in the domains of mental health and pain management, and is advancing a strong pipeline of proprietary drug candidates through various stages of clinical trials. Tonix's expertise in drug formulation and deli...

GNG Research Analysis

GNG Research scores Tonix Pharmaceuticals Holding Corp (TNXP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TNXP.

Frequently Asked Questions

Does TNXP pay dividends?

Tonix Pharmaceuticals Holding Corp (TNXP) does not currently pay a regular dividend.

What is TNXP's market cap?

Tonix Pharmaceuticals Holding Corp (TNXP) has a market capitalization of $195.91M with a current stock price of $11.72.